Table 4.
Variable | HR | 95% Confidence Interval | P Value |
---|---|---|---|
Dopamine infusion time ≥7.1 h | 0.52 | 0.29 to 0.94 | 0.03 |
Donor age, yr | 1.02 | 1.00 to 1.04 | 0.01 |
Female donor | 1.03 | 0.71 to 1.50 | 0.88 |
Donor systolic BP, mmHg | 1.00 | 0.99 to 1.01 | 0.93 |
Donor diastolic BP, mmHg | 1.00 | 0.98 to 1.02 | 0.99 |
Donor urine production last h, ml | 1.00 | 0.998 to 1.001 | 0.79 |
Head trauma, yes | 1.20 | 0.74 to 1.94 | 0.46 |
Cerebral stroke, yes | 0.89 | 0.49 to 1.61 | 0.69 |
Cerebral ischemia/cerebral edema, yes | 0.42 | 0.18 to 1.00 | 0.05 |
Time from admission on ICU to brain-death confirmation, d | 1.01 | 0.97 to 1.05 | 0.65 |
Time from brain-death confirmation to organ procurement, h | 1.00 | 0.96 to 1.05 | 0.86 |
Multiorgan versus kidney-only donor, yes | 1.02 | 0.67 to 1.55 | 0.93 |
Cold ischemic time, h | 1.01 | 0.97 to 1.04 | 0.72 |
Recipient age, yr | 1.03 | 1.01 to 1.05 | 0.001 |
Female recipient | 1.34 | 0.91 to 1.99 | 0.14 |
Recipient weight, kg | 1.01 | 0.99 to 1.02 | 0.14 |
Recipient diabetes, yes | 1.86 | 1.10 to 3.12 | 0.02 |
Time spent on waiting list, yr | 1.00 | 0.94 to 1.07 | 0.95 |
Antigen mismatches A, B, and DR, n | 1.05 | 0.93 to 1.18 | 0.45 |
Panel reactive antibody >5%, yes | 1.22 | 0.70 to 2.14 | 0.48 |
Repeat transplant, yes | 2.10 | 1.28 to 3.46 | 0.003 |
Induction therapy, yes | 0.84 | 0.59 to 1.19 | 0.33 |
Tacrolimus versus cyclosporinea | 0.78 | 0.53 to 1.14 | 0.20 |
Analyses cover the entire trial cohort including control patients. HR, hazard ratio; ICU, intensive care unit.
At time of transplantation.